Insider Transactions Reported by 21 Insiders of Esperion Therapeutics, Inc.

Symbol
ESPR on Nasdaq
Industry
Pharmaceutical Preparations
Location
Ann Arbor, MI

Insiders trading volume in the past year

Esperion Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Biotech Target N V 10%+ Owner $5.58M May 24, 2021
Sheldon L. Koenig President and CEO, Director $4.23M -$163K -3.71% Sep 17, 2025
Benjamin Halladay Chief Financial Officer $1.33M -$41.3K -3% Sep 17, 2025
John B. Harlow Jr. Chief Commercial Officer $1.32M Dec 4, 2025
Benjamin Looker General Counsel $1.03M -$29.7K -2.8% Oct 17, 2025
Joanne M. Foody Chief Medical Officer $709K Jul 17, 2024
Eric Warren Chief Commercial Officer $362K -$9.87K -2.65% Apr 17, 2025
Alan Fuhrman Director $133K May 23, 2024
Gotto Antonio M Jr Md D Phil Director $128K May 23, 2024
Richard Bartram Chief Financial Officer $103K Mar 14, 2022
J. Martin Carroll Director $78.1K May 29, 2025
Jay Shepard Director $67.7K May 29, 2025
Daniel Janney Director $59.8K May 27, 2021
Stephen Rocamboli Director $55.4K May 29, 2025
H. Fischer Seth Director $48.9K May 29, 2025
Mark E. Mcgovern Director $35.4K May 27, 2021
Robert E. Hoffman Director $4.22K May 29, 2025
Jeffrey Berkowitz Director May 26, 2022
Nicole Vitullo Director May 29, 2025
John Craig Thompson Director Jul 1, 2025
Tracy M. Woody Director May 29, 2025

Recent Insider Transactions by Companies or Individuals for Esperion Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.